Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. F. Whitecross
Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
The Histone Deacetylase Inhibitor Romidepsin Induces as a Cascade of Differential Gene Expression and Altered Histone H3K9 Marks in Myeloid Leukaemia Cells
Oncotarget
Oncology
Effect of Histone Deacetylase Inhibitor Romidepsin on the in Vitro Growth of Foetal Fibroblast Cells and Early Development of Porcine-Cloned Embryos
Italian Journal of Animal Science
The Effects of the Histone Deacetylase Inhibitor Romidepsin (FK228) Are Enhanced by Aspirin (ASA) in COX-1 Positive Ovarian Cancer Cells Through Augmentation of P21
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Histone Deacetylase Inhibitor Downregulation of BCL-Xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Journal of Biomedicine and Biotechnology
P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
Ischemic Preconditioning, Retinal Neuroprotection and Histone Deacetylase Activities
Experimental Eye Research
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Romidepsin Enhances the Efficacy of Cytarabine in Vivo, Revealing Histone Deacetylase Inhibition as a Promising Therapeutic Strategy for KMT2A-rearranged Infant Acute Lymphoblastic Leukemia
Haematologica
Hematology
